AU Patent

AU2018307910B2 — Formulations of a compound modulating kinases

Assigned to Daiichi Sankyo Co Ltd · Expires 2024-07-25 · 2y expired

What this patent protects

Provided are compositions comprising Compound I having the following structure: Compound I or a pharmaceutically acceptable salt thereof, and a solubilizing agent; method of making the same; and methods of using the same.

USPTO Abstract

Provided are compositions comprising Compound I having the following structure: Compound I or a pharmaceutically acceptable salt thereof, and a solubilizing agent; method of making the same; and methods of using the same.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018307910B2
Jurisdiction
AU
Classification
—
Expires
2024-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Daiichi Sankyo Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.